Compounds > thiazoles
Page last updated: 2024-08-21

thiazoles and Endocarditis, Loeffler

thiazoles has been researched along with Endocarditis, Loeffler in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (33.33)18.2507
2000's1 (33.33)29.6817
2010's1 (33.33)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Baumgartner, C; Bennett, KL; Esterbauer, H; Ferenc, V; Gleixner, KV; Gruze, A; Lee, FY; Peter, B; Pickl, WF; Remsing Rix, LL; Samorapoompichit, P; Sillaber, C; Superti-Furga, G; Valent, P1
Harada, H; Harada, Y; Imagawa, J; Kimura, A; Matsumoto, K; Morita, K; Tarutani, M; Yoshida, T1
Kiriyama, Y; Nochi, H; Sakurada, Y; Sugimura, A; Tamoto, K; Tokumitsu, Y; Tsuchiya, H; Ui, M1

Other Studies

3 other study(ies) available for thiazoles and Endocarditis, Loeffler

ArticleYear
Dasatinib inhibits the growth and survival of neoplastic human eosinophils (EOL-1) through targeting of FIP1L1-PDGFRalpha.
    Experimental hematology, 2008, Volume: 36, Issue:10

    Topics: Apoptosis; Cell Division; Cell Line, Tumor; Cell Survival; Dasatinib; DNA Replication; Eosinophils; Flow Cytometry; Humans; Hypereosinophilic Syndrome; mRNA Cleavage and Polyadenylation Factors; Protein Kinase Inhibitors; Pyrimidines; Sequence Deletion; Thiazoles; Thymidine

2008
[Successful treatment with low-dose dasatinib in a patient with chronic eosinophilic leukemia intolerant to imatinib].
    [Rinsho ketsueki] The Japanese journal of clinical hematology, 2011, Volume: 52, Issue:7

    Topics: Aged; Benzamides; Chronic Disease; Dasatinib; Drug Monitoring; Drug Tolerance; Humans; Hypereosinophilic Syndrome; Imatinib Mesylate; Male; Molecular Targeted Therapy; mRNA Cleavage and Polyadenylation Factors; Piperazines; Pyrimidines; Receptor, Platelet-Derived Growth Factor alpha; Remission Induction; Thiazoles; Treatment Outcome

2011
Troglitazone suppresses cell growth of myeloid leukemia cell lines by induction of p21WAF1/CIP1 cyclin-dependent kinase inhibitor.
    Biochemical and biophysical research communications, 1999, Aug-11, Volume: 261, Issue:3

    Topics: Antineoplastic Agents; Cell Cycle; Cell Division; Chromans; Cyclin-Dependent Kinase Inhibitor p21; Cyclins; DNA; Enzyme Inhibitors; Flow Cytometry; Gene Expression; Humans; Hypereosinophilic Syndrome; Leukemia, Myeloid; Leukemia, Myelomonocytic, Acute; Leukemia, Myelomonocytic, Chronic; RNA, Messenger; Thiazoles; Thiazolidinediones; Troglitazone; Tumor Cells, Cultured

1999